Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems

Metabolic Brain Disease

Volumn 30, Issue 1, 2015, Pages 129-136

  Chen, Jianliang ^a   Lin, Dan ^b   Zhang, Chong ^c   Li, Gaowen ^d   Zhang, Nianping ^e   Ruan, Lina ^c   Yan, Qizhi ^c   Li, Jianxin ^c   Yu, Xuefeng ^c   Xie, Xupei ^c   Pang, Cong ^c   Cao, Liang ^c   Pan, Jianchun ^c   Xu, Ying ^b,c  

^a YIXING PEOPLE S HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY AT BUFFALO   (United States)

^d Ningbo College of Health Sciences   (China)

^e Datong University Health Science Center   (China)

Author keywords

Antidepressant; Ferulic acid; Monoamine oxidase; Norepinephrine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; DOPAMINE; FERULIC ACID; IMIPRAMINE; NORADRENALIN; SEROTONIN; AMINE OXIDASE (FLAVIN CONTAINING); COUMARIC ACID; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; EXPERIMENTAL DEPRESSION TEST; FORCED SWIM TEST; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; IMMOBILITY; LOCOMOTION; MALE; MOOD DISORDER; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; EXERCISE; FRONTAL LOBE; IMMOBILIZATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; MOTOR ACTIVITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORPUS STRIATUM; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FRONTAL LOBE; HIPPOCAMPUS; HYPOTHALAMUS; IMIPRAMINE; IMMOBILIZATION; MALE; MICE; MICE, INBRED ICR; MOCLOBEMIDE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NOREPINEPHRINE; PHYSICAL EXERTION; SEROTONIN; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84925489787     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9635-z     Document Type: Article

References (29)

1. Abdel-Razaq W, Kendall DA, Bates TE (2011) The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochem Res 36:327–38
2. Butterweck V, Böckers T, Korte B et al (2002) Long-term effects of St. John’s wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res 930:21–9
3. D’Aquila PS, Collu M, Gessa GL, Serra G (2000) The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405:365–73
4. Dar A, Khatoon S (2000) Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacol Biochem Behav 65:1–6
5. Ibtissem B, Abdelly C, Sfar S (2012) Antioxidant and Antibacterial Properties of Mesembryanthemum crystallinum and Carpobrotus edulis Extracts. 2012:359–365
6. Judd LL, Schettler PJ, Coryell W, Akiskal HS, Fiedorowicz JG (2013) Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course. JAMA Psychiatry 70:1171–80
7. Kemmotsu N, Kucukboyaci NE, Cheng CE, Girard HM, Tecoma ES, Iragui VJ, McDonald CR (2013) Alterations in functional connectivity between the hippcampus and prefrontal cortex as a correlate of depressive symptoms in temporal lobe epilepsy. Epilepsy Behav 29:552–559
8. Khisti RT, Chopde CT, Jain SP (2000) Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67:137–43
9. Machado MG, Bettio LE, Cunha MP, Capra JC, Dalmarco JB, Pizzolatti MG, Rodrigues AL (2009) Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of monoaminergic system. Prog Neuropsychopharmcol Biol Psychiatry 33:642–50
10. Marks DM, Pae C-U, Patkar A (2008) Triple reuptake inhibitors: the next generation of antidepressants. Curr Neuropharmacol 6:338–43
11. Montgomery SA (1997) Is there a role for a pure noradrenergic drug in the treatment of depression? Eur Neuropsychopharmacol 7 Suppl 1:S3–9; discussion S71–3.
12. Naughton M, Mulrooney JB, Leonard BE (2000) A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 15:397–415
13. Nemeroff CB, Owens MJ (2002) Treatment of mood disorders. Nat Neurosci 5(Suppl):1068–70
14. Nitta A, Furukawa Y, Hayashi K et al (1992) Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci Lett 144:152–6
15. Piñeyro G, Blier P (1999) Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51:533–91
16. Rojas P, Serrano-García N, Medina-Campos ON et al (2011) Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress. Neurochem Int 59:628–36
17. Sultana R, Ravagna A, Mohmmad-Abdul H et al (2005) Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92:749–58
18. Valente KD, Busatto Filho G (2013) Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences. Arq Neuropsiquiatr 71:183–190
19. Wąsik A, Możdżeń E, Michaluk J et al (2014) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous Neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat. Neurotox Res 25:323–34
20. Xu Y, Ku B-S, Yao H-Y et al (2005a) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518:40–6
21. Xu Y, Ku B-S, Yao H-Y et al (2005b) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200–6
22. Xu Y, Wang Z, You W et al (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 20:405–13
23. Xu Y, Zhang L, Shao T et al (2013) Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 28:571–83
24. Yabe T, Hirahara H, Harada N et al (2010) Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 165:515–24
25. Yan JJ, Cho JY, Kim HS et al (2001) Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89–96
26. Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness. Br J Pharmacol 147(Suppl):S287–96
27. Zeni ALB, Zomkowski ADE, Maraschin M et al (2012) Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system. Eur J Pharmacol 679:68–74
28. Zhang Y, Huang X, Wang Y et al (2011) Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology. Brain Res Bull 86:222–8
29. Zhen L, Zhu J, Zhao X et al (2012) The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav Brain Res 228:359–66